{
    "clinical_study": {
        "@rank": "36856", 
        "arm_group": {
            "arm_group_label": "Cultivated mucosal epithelial transplant", 
            "arm_group_type": "Experimental", 
            "description": "Cultivated mucosal epithelial transplantaion to limbal deficiency patients"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to elucidate the appropriate condition of  developing\n      cultivated autologous oral mucosal epithelial graft and evaluate the surgical outcome of\n      transplantation of the cultivated cells in the patients."
        }, 
        "brief_title": "Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Ocular Surface Disease", 
        "detailed_description": {
            "textblock": "Ocular surface damage caused by severe ocular surface diseases. Corneal limbal stem cell\n      transplantation has been demonstrated to improve the outcome of ocular surface\n      reconstruction. However, the conventional management of allograft limbal transplantation\n      generally has unsatisfactory outcome because of high risk of rejection and requires\n      long-life immunosuppressive medications. Ocular surface reconstruction with cultivated\n      autologous mucosal epithelial transplantation is served to improve the surgical results of\n      ocular surface reconstruction and decrease the use of immunosuppressive medications"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Bilateral limbal stem cell deficiency proved by specific clinical features and\n             impression cytology\n\n        Exclusion Criteria:\n\n          -  Age under 18\n\n          -  Active ocular infection, Severe dry eye, Uncontrolled glaucoma\n\n          -  Immunocompromised host\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 6, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01942421", 
            "org_study_id": "639/2551(EC2)"
        }, 
        "intervention": {
            "arm_group_label": "Cultivated mucosal epithelial transplant", 
            "description": "cultivated autologous mucosal epithelium, then transplant to limbal stem cell deficiency patients.", 
            "intervention_name": "Cultivated mucosal epithelial transplantation", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Limbal deficiency", 
            "Cultivated limbal transplantation", 
            "Ex vivo limbal transplantation", 
            "Cultivated autologous mucosal epithelial transplantation"
        ], 
        "lastchanged_date": "September 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10300"
                }, 
                "name": "Pinnita Prabhasawat, MD"
            }
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "1", 
        "official_title": "Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation.", 
        "overall_official": {
            "affiliation": "Mahidol University", 
            "last_name": "Pinnita Prabhasawat, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Ocular surface clinical and pathological status(signs of limbal deficiency and immunopathological markers)after the surgery", 
            "safety_issue": "Yes", 
            "time_frame": "Three years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01942421"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mahidol University", 
            "investigator_full_name": "Pinnita Prabhasawat", 
            "investigator_title": "Associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Mahidol University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mahidol University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}